| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/20014091084173 |
| P698 | PubMed publication ID | 11256517 |
| P2093 | author name string | Banerjee S | |
| Farrell RJ | |||
| Peppercorn MA | |||
| P2860 | cites work | Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking | Q22242044 |
| Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics | Q22242875 | ||
| Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice | Q28139615 | ||
| A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators | Q28145430 | ||
| Mapping of a susceptibility locus for Crohn's disease on chromosome 16 | Q28275042 | ||
| Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease | Q28278595 | ||
| Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance | Q28307567 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones | Q29622840 | ||
| The relationship between infliximab treatment and lymphoma in Crohn's disease | Q30304487 | ||
| Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. | Q30581062 | ||
| Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy | Q33332618 | ||
| Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial | Q33617982 | ||
| Molecular and cellular effects of methotrexate | Q33635748 | ||
| Modulation by cytokines of glucocorticoid action. | Q33692675 | ||
| Composition of human colonic mucin. Selective alteration in inflammatory bowel disease | Q33821817 | ||
| Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease | Q33825052 | ||
| Infliximab for the treatment of fistulas in patients with Crohn's disease | Q33860666 | ||
| Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial | Q33872486 | ||
| Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group | Q33885648 | ||
| Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease | Q33895677 | ||
| Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group | Q33927770 | ||
| Familial occurrence of inflammatory bowel disease | Q34019830 | ||
| Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction | Q34043306 | ||
| Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 | ||
| Stress and infectious disease in humans | Q34091941 | ||
| Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis | Q34260899 | ||
| Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin | Q34290465 | ||
| Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease | Q34375240 | ||
| Frequency of glucocorticoid resistance and dependency in Crohn's disease | Q34378274 | ||
| Double blind, placebo controlled trial of metronidazole in Crohn's disease | Q34394436 | ||
| Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect | Q34395594 | ||
| Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial | Q34395737 | ||
| Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. | Q34408465 | ||
| Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction | Q34408871 | ||
| Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease | Q34409290 | ||
| Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial | Q34418343 | ||
| Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis | Q41862338 | ||
| Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease | Q41893726 | ||
| The jejunal secretion of histamine is increased in active Crohn's disease | Q41933777 | ||
| 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity | Q42255552 | ||
| Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease | Q42439317 | ||
| Effects of mesalamine on the hsp72 stress response in rat IEC-18 intestinal epithelial cells | Q42446269 | ||
| Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study | Q42547552 | ||
| Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. | Q42629318 | ||
| Inflammatory bowel disease--a radical view | Q43212912 | ||
| The colonic epithelium in ulcerative colitis: an energy-deficiency disease? | Q44887371 | ||
| Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats | Q45098707 | ||
| Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. | Q45118258 | ||
| Absence of measles-virus genome in inflammatory bowel disease | Q45757483 | ||
| Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice | Q46046024 | ||
| Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. | Q46185993 | ||
| Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease | Q46221692 | ||
| Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease | Q46292918 | ||
| A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease | Q46520994 | ||
| Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb | Q47070747 | ||
| Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children | Q47677013 | ||
| Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease | Q47787267 | ||
| Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease | Q47848068 | ||
| Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells | Q48019534 | ||
| Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor | Q48059051 | ||
| Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis | Q48059532 | ||
| Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. | Q48479409 | ||
| Transdermal nicotine for active ulcerative colitis. | Q48848039 | ||
| No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. | Q50301910 | ||
| Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. | Q50883754 | ||
| Topical treatment of ulcerative proctitis with lidocaine. | Q51746895 | ||
| Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. | Q52051526 | ||
| Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. | Q53001279 | ||
| An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. | Q53536563 | ||
| Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. | Q53540951 | ||
| Oral budesonide as maintenance therapy in Crohn's disease--results of a 12-month study. Global Budesonide Study Group. | Q53743754 | ||
| Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. | Q53921400 | ||
| A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. | Q53964227 | ||
| Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). | Q54005785 | ||
| A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. | Q54344506 | ||
| Enteric Microflora in IBD: Pathogens or Commensals? | Q54558514 | ||
| Fecal Hydrogen Sulfide Production in Ulcerative Colitis | Q56094845 | ||
| Ketotifen therapy for acute ulcerative colitis in children: a pilot study | Q56119384 | ||
| Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease | Q56119397 | ||
| Stimulation of transforming growth factor β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis | Q57241201 | ||
| Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16 | Q57310451 | ||
| Childhood Exposure to Environmental Tobacco Smoke and the Risk of Ulcerative Colitis | Q57420426 | ||
| Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease | Q59120722 | ||
| Methotrexate for the Treatment of Crohn's Disease | Q59120846 | ||
| Low-Dose Cyclosporine for the Treatment of Crohn's Disease | Q59120870 | ||
| Childhood infections and the risk of inflammatory bowel disease | Q39398913 | ||
| Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats | Q39769547 | ||
| Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease | Q39794841 | ||
| Prostaglandins and ulcerative colitis | Q40096108 | ||
| Interleukin-10 gene knock-out mice: a model of chronic inflammation. | Q40411019 | ||
| Oxidants and free radicals in inflammatory bowel disease | Q40625906 | ||
| Stress and immunity in humans: a meta-analytic review | Q40866873 | ||
| Nicotine enemas for active ulcerative colitis--a pilot study | Q40879021 | ||
| Preliminary evidence for genetic anticipation in Crohn's disease | Q40982234 | ||
| Differential expression of interleukin 1 receptor antagonist isoforms in human intestinal epithelial cells | Q40991409 | ||
| Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment | Q41222602 | ||
| Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis | Q41283113 | ||
| Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids | Q41283123 | ||
| Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years | Q41354684 | ||
| Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions | Q41355139 | ||
| Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine | Q41406785 | ||
| Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study | Q41466547 | ||
| Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications | Q41467437 | ||
| Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta | Q41517331 | ||
| Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids | Q41566551 | ||
| Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease | Q41581823 | ||
| The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease | Q41666854 | ||
| Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease | Q41748164 | ||
| The influence of zinc status and malnutrition on immunological function in Crohn's disease | Q41775346 | ||
| Leucocyte endothelial cell adhesion in indomethacin induced intestinal inflammation is correlated with faecal pH. | Q41789374 | ||
| Genetic markers may predict disease behavior in patients with ulcerative colitis | Q34428379 | ||
| Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group | Q34434612 | ||
| Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis | Q34465376 | ||
| Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial | Q34510060 | ||
| Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement | Q34525820 | ||
| Role of the faecal stream in the maintenance of Crohn's colitis | Q34526492 | ||
| Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens | Q34528036 | ||
| Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse | Q34530099 | ||
| Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum | Q34531935 | ||
| Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease | Q34532797 | ||
| Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis | Q34544013 | ||
| Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease | Q35349274 | ||
| Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study | Q35350348 | ||
| Effects of smoking on the urine excretion of oral 51Cr EDTA in ulcerative colitis | Q35350725 | ||
| Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines | Q35351431 | ||
| High Fas ligand expression on lymphocytes in lesions of ulcerative colitis | Q35351584 | ||
| Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease | Q35355186 | ||
| Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P | Q35660591 | ||
| Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial | Q35707325 | ||
| The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats | Q36364133 | ||
| T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice | Q36365428 | ||
| Antibodies to interleukin 12 abrogate established experimental colitis in mice | Q36365464 | ||
| Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance | Q36366774 | ||
| Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice | Q36367158 | ||
| Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils | Q36383341 | ||
| CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease | Q36400483 | ||
| Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. | Q36493604 | ||
| Crohn's disease and the mycobacterioses: a review and comparison of two disease entities | Q36634773 | ||
| Smoking, the oral contraceptive pill, and Crohn's disease | Q37222343 | ||
| Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease | Q37357109 | ||
| Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. | Q37361157 | ||
| Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis | Q37361932 | ||
| Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis | Q37385642 | ||
| Apoptosis of human intestinal epithelial cells after bacterial invasion | Q37387961 | ||
| P433 | issue | 1 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 33-108 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Critical Reviews in Clinical Laboratory Sciences | Q5186664 |
| P1476 | title | Recent advances in inflammatory bowel disease. | |
| P478 | volume | 38 |
| Q35202922 | Advances in clinical laboratory tests for inflammatory bowel disease |
| Q36656427 | Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date |
| Q43263390 | Colitis: it is not just for the colon anymore |
| Q42911564 | Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats. |
| Q46632504 | Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon |
| Q35881756 | Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease |
| Q35128668 | Probiotics and Inflammatory Bowel Disease |
| Q34669243 | Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis |
| Q36496776 | Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study |
Search more.